Impact of the hospital pharmacy initiative for promoting prudent use of antibiotics in hospitals in England

Journal of Antimicrobial Chemotherapy

Volumn 58, Issue 6, 2006, Pages 1230-1237

  Wickens, Harley J ^a   Jacklin, A ^a  

^a IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

Antibacterials; Antibiotic management; Antibiotic pharmacist; Antibiotic policy; Pharmacist

Indexed keywords

ANTIBIOTIC AGENT;

ARTICLE; COST CONTROL; DRUG CONTROL; DRUG COST; DRUG MONITORING; DRUG UTILIZATION; FUNDING; HOSPITAL PERSONNEL; HOSPITAL PHARMACY; HUMAN; HUMAN EXPERIMENT; MEDICAL AUDIT; PHARMACIST; PHARMACY TECHNICIAN; PRESCRIPTION; QUESTIONNAIRE; UNITED KINGDOM;

ANTI-BACTERIAL AGENTS; DRUG COSTS; DRUG UTILIZATION REVIEW; ENGLAND; HUMANS; PHARMACY SERVICE, HOSPITAL; PRESCRIPTIONS, DRUG; PROGRAM EVALUATION; QUESTIONNAIRES;

EID: 33845350829     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl405     Document Type: Article

References (37)

1. The Audit Commission 2001. A Spoonful of Sugar - Medicines Management in NHS Hospitals, www.audit-commission.gov.uk (22 July 2005, date last accessed).
2. Schumock GT, Butler MG, Meek PD et al. Evidence of economic benefits of clinical pharmacy services: 1996-2000. Pharmacother 2003; 23:113-32.
3. Coleman RW, Rondondi LC, Kaubisch S et al. Cost-effectiveness of prospective and continuous parenteral antibiotic control: Experience at the Palo Alto Veterans Affairs Medical Center from 1987 to 1989. Am J Med 1991; 30: 439-43.
4. Glowacki RC, Schwartz DN, Itokazu GS et al. Antibiotic combinations with redundant antimicrobial spectra: Clinical epidemiology and pilot intervention of computer-assisted surveillance. Clin Infect Dis 2003;37:59-64.
5. Gross R, Morgan AS, Kinky DE et al. Impact of a hospital-based antimicrobial management program on clinical and economic outcomes. Clin Infect Dis 2001; 33: 289-95.
6. Josafiak ET, Lewicki JE, Kozinn JP. Computer-assisted antimicrobial surveillance in a community teaching hospital. Am J Health-Syst Pharm 1995; 52: 1536-40.
7. Dickerson LM, Mainous AG, Carek AJ. The pharmacist's role in promoting optimal antimicrobial use. Pharmacother 2000; 20: 711-23.
8. Ibrahim KH, Gunderson B, Rotschafer JC. Intensive care unit antimicrobial resistance and the role of the pharmacist. Crit Care Med 2001; 29 Suppl.: N108-13.
9. Knox K, Lawson W, Dean B et al. Multidisciplinary antimicrobial management and the role of the infectious diseases pharmacist - a UK perspective. J Hosp, Infect 2003; 53: 85-90.
10. Cooke J. Antimicrobial management: The role of clinical pharmacists. Hosp Pharm 2003; 10: 392-400.
11. Wickens HJ, Wade PA. How pharmacists can promote the sensible use of antimicrobials. Pharm J 2005; 274: 427-30.
12. Hand K, Lawson W. A career as a specialist microbiology pharmacist. Hosp Pharm 2004; 11: 459-64.
13. Weller TMA, Jamieson CE. The expanding role of the antibiotic pharmacist. J Antimicrob Chemother 2004; 54: 295-8.
14. Jepson AJ, Wickens HJ. What does a microbiology pharmacist do? Pharm J 2003; 271: 774-5.
15. Chief Medical Officer/Chief Pharmaceutical Officer 2003. Hospital Pharmacy Initiative for Promoting Prudent Use of Antibiotics in Hospitals (Letter) PL/CMO/2003/3, PL/PhO/2003/3 Department of Health, London., www.doh.gov.uk/cmo/cmo/letters/cmo0303.pdf (29 July 2006, date last accessed).
16. Foddy W. Constructing Questions for Interviews and Questionnaires: Theory and Practice in Social Research. Cambridge: Cambridge University Press, 1993.
17. Marshall C, Rossman GB. Designing Qualitative Research. 2nd edn. London: Sage Publications, 1995.
18. Jesson J. Cross-sectional studies in prescribing research. J Clin Pharm Ther 2001; 26: 397-403.
19. Denscombe M. The Good Research Guide for Small Scale Social Research Projects, 2nd edn. Maidenhead: Open University Press, 2003.
20. Edwards P, Roberts I, Clarke M et al. Increasing response rates to postal questionnaires: Systematic review. Br Med J 2002; 324: 1183-91.
21. Wylie S, Weeks C, Khachi K et al. Re: Knox et al., Multidisciplinary antimicrobial management and the role of the infectious diseases pharmacist - a UK perspective. J Hosp Infect 2003; 54: 246.
22. Ramsay C, Brown E, Hartman G et al. Room for improvement: A systematic review of the quality of interventions to improve hospital antibiotic prescribing. J Antimictob Chemother 2003; 52: 764-71.
23. Department of Health 2003. Winning Ways: Working Together to Reduce Healthcare Associated Infection in England. www.dh.gov.uk/assetRoot/04/ 06/46/89/04064689.pdf (7 September 2006, date last accessed).
24. Nathwani D. Antimicrobial prescribing policy and practice in Scotland: recommendations for good antimicrobial practice in acute hospitals. J Antimicrob Chemother 2006; 57: 1189-96.
25. Healthcare Commission 2004. Acute Hospital Portfolio. www.healthcarecommission.org.uk/serviceproviderinformation/ reviewsandinspections/acutehospitalportfolio.cfm (7 September 2006, date last accessed).
26. Woodford EM, Wilson KA, Marriott JF. Documentation of antibiotic prescribing controls in UK hospitals. J Antimicrob Chemother 2004; 53: 650-2.
27. Cooke J, Mason A, Drummond MF at al. Medication management in English National Health Service Hospitals. Am J Health-Syst Pharm 2005; 62: 189-95.
28. Woodford EM, Wilson KA, Marriott JF. Professionals awareness of operational antibiotic prescribing controls in UK NHS hospitals. J Hosp Infect 2004; 58: 193-9.
29. Ansari F, Gray K, Nathwani D et al. Outcomes of an intervention to improve hospital antibiotic prescribing: Interrupted time series with segmented regression analysis. J Antimicrob Chemother 2003; 52: 842-8.
30. Curtis C, Marriott J, Langley C. Development of a prescribing indicator for objective quantification of antibiotic usage in secondary care. J Antimicrob Chemother 2004; 54: 529-33.
31. Salzy-Callert S, Causse R, Furhman C et al. Impact of a multidisciplinary approach to the control of antibiotic prescription in a general hospital. J Hosp Infect 2003; 53:177-82.
32. Dean B, Lawson W, Jacklin A et al. The use of serial pointprevalence studies to investigate hospital anti-infective prescribing. Int J Pharm Pract 2002; 10: 121-5.
33. Holmes AH, Murray E, Dineen M. Creating a New Culture. Public Service Review, www.publicservice.co.uk/pdf/health/issue8/ HB%20Dr%20Alison%20Holmes%20ATL.pdf (7 September 2006, date last accessed).
34. Owens RC, Fraser GL, Stogsdill P. Antimicrobial stewardship programs as a means to optimize antimicrobial use. Pharmacother 2004; 24: 896-908.
35. Jensen KM, Paladino JA. Cost-effectiveness of abbreviating the duration of intravenous antibacterial therapy with oral fluoroquinolones. Pharmacoeconomics 1997; 11: 64-74.
36. Giamarellou H, Bassaris HP, Petrikkos G et al. Monotherapy with intravenous followed by oral high-dose ciprofloxacin versus combination therapy with ceftazidime plus amikacin as initial empiric therapy for granulocytopenic patients with fever. Antimicrob Agents Chemother 2000; 44: 3264-71.
37. Pablos IA, Escobar I, Albinana S et al. Evaluation of an antibiotic intravenous to oral sequential therapy program. Pharmacoepidemiol Drug Saf 2005; 14: 53-9.